nimodipine has been researched along with Tachycardia, Supraventricular in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Tachycardia, Supraventricular: A generic expression for any tachycardia that originates above the BUNDLE OF HIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qi, XY | 1 |
Yeh, YH | 1 |
Xiao, L | 1 |
Burstein, B | 1 |
Maguy, A | 1 |
Chartier, D | 1 |
Villeneuve, LR | 1 |
Brundel, BJ | 1 |
Dobrev, D | 1 |
Nattel, S | 1 |
1 other study available for nimodipine and Tachycardia, Supraventricular
Article | Year |
---|---|
Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current.
Topics: Action Potentials; Animals; Calcineurin; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium | 2008 |